Research Supervision
| Number of current supervisions | 3 |
|---|
| Total current UoN PhD EFTSL | 1.1 |
|---|
For supervisions undertaken at an institution other that the University of Newcastle, details are shown in italics, and the institution name is listed below the program name.
Current Supervision
| Commenced | Proposed
Completion | Program | Supervisor Type | Research Title |
|---|
| 2011 | 2015 | PhD (Immunology & Microbiol) | Co-Supervisor | Combination of Oncolytic Coxsackievirus A21 with Conventional Chemotherapy for the Treatment of Melanoma |
| 2011 | 2015 | PhD (Immunology & Microbiol) | Co-Supervisor | Investigation of Oncolytic Coxsackievirus A21 as a Potential Treatment for Lung Cancer |
| 2010 | 2014 | PhD (Immunology & Microbiol) | Co-Supervisor | Low Pathogenic Human Enteroviruses as a Novel Anti-cancer Agent against Malignant Glioma |
Past Supervision
| Year | Program | Supervisor Type | Research Title |
|---|
| 2009 | PhD (Immunology & Microbiol) | Principal Supervisor | Enteroviral-Mediated Oncolysis of Cancer: Evaluation of Efficacy and Obstacles to Therapeutic Success |
| 2009 | PhD (Immunology & Microbiol) | Principal Supervisor | Enteroviruses as Novel Oncolytic Agents for the Control of Human Prostate Cancer |
| 2008 | PhD (Immunology & Microbiol) | Principal Supervisor | Viral Oncolysis of Human Breast Cancer |
| 2005 | PhD (Immunology & Microbiol) | Principal Supervisor | Control of Cancer Progression by Virotherapy |
| 2003 | PhD (Immunology & Microbiol) | Sole Supervisor | Mechanisms of Cell Entry and Release of Coxsackievirus B3 (CVB3) |
| 2003 | PhD (Immunology & Microbiol) | Principal Supervisor | Cellular Receptor Interactions of C Cluster Coxsackie A Viruses |